IMVT — Immunovant Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates IMVT Bullish with a Setup Score of 0, net conviction 26, actionability 0. How the Setup Score works →

Total Setup Score0
Directional BiasBullish
Net Conviction26
Actionability0 (extended)

Key signals behind this score

About Immunovant Inc

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$38.79
Market Cap$7.96B
Float78.7M
Shares Outstanding205.3M
vs. Analyst Target+18.6% to analyst PT
Dividend RateNone
Analyst Target Price$46.00 (14 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2021 N/A -$107M -$998,000 -$108M
2022 N/A -$157M -$1.2M -$157M
2023 N/A -$211M -$1.3M -$198M
2024 N/A -$259M -$231,000 -$259M
2025 N/A -$414M -$377,000 -$413M
2026 N/A -$506M -$409,000 -$505M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$121M
Sep 2025 N/A -$127M
Dec 2025 N/A -$111M
Mar 2026 N/A -$148M

Ownership & Float

Insider Ownership56.6%
Institutional Ownership54.7%
Short Float24.6%
% of All Funds Holding2.40%
Number of Funds Holding197

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$32.87Near-term / short-term trend
Weekly40-Week SMA$26.55Medium-term trend
Weekly80-Week SMA$22.14Cyclical trend (business cycle)
Weekly200-Week SMA$23.84Secular trend (multi-year)
Monthly10-Month SMA$29.06Near-term monthly trend
Monthly20-Month SMA$23.43Medium-term monthly trend
Monthly40-Month SMA$26.31Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$33.00 support 1.02x 0 months ago
$27.30 support 1.44x 1 months ago
$23.80 support 1.03x 2 months ago
$16.20 support 1.34x 8 months ago

Historical Earnings Reactions (28 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.17% 0.08% 50.00% 4.26% -6.32%
1 Day 1.32% 1.15% 60.71% 18.61% -10.69%
1 Week -0.04% -0.08% 46.43% 19.38% -14.00%
2 Weeks 1.65% 1.71% 64.29% 29.83% -13.48%
1 Month 2.24% 0.81% 51.85% 43.63% -40.48%

Next earnings: August 10, 2026 (36 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-8.2%28.6%7
Feb-11.9%14.3%7
Mar-6.9%14.3%7
Apr-0.9%42.9%7
May9.2%42.9%7
Jun-3.7%42.9%7
Jul4.0%57.1%7
Aug8.0%57.1%7
Sep12.1%85.7%7
Oct22.9%71.4%7
Nov5.9%57.1%7
Dec13.2%71.4%7

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.20% 48.0% 331
Tuesday -0.04% 47.9% 365
Wednesday 0.28% 48.8% 361
Thursday 0.35% 49.0% 353
Friday 0.14% 47.6% 353

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 54.7%

Insider Transactions — Smart Summary

Total insider ownership: 56.6%

12-Month Insider Activity Summary

Total Filings34
Net Value-$9.0M
Net Shares Change16,456,555
% of Float20.9%
C-Suite Filings26
Clusters Detected4

Key Insiders

NameTitleNet ValueFilingsActivity
Roivant Sciences Ltd. +$350M 1 1 buy
Fromkin Andrew J. -$5.8M 1 1 sell
Venker Eric Chief Executive Officer -$3.4M 1 1 sell
Stout Jay S Chief Technology Officer -$1.5M 1 1 sell
Girao Tiago Chief Financial Officer -$988,611.2 2 1 sell
Gloria Melanie Chief Operating Officer -$678,603.855 1 1 sell
Van Tuyl Christopher Chief Legal Officer -$540,209.497 2 1 sell
Susman Robert Graham -$67,979.34 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-11-21 – 2025-12-03 3 3 -$1.2M 1 C-suite
2026-04-10 – 2026-04-24 5 4 -$1.4M 5 C-suite
2026-05-20 – 2026-05-29 3 3 -$6.1M 1 C-suite
2026-06-16 – 2026-06-26 7 5 -$3.0M 5 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-06-26 Stout Jay S Chief Technology Officer -$1.5M Transaction at $38.31, now +1.3%
2026-06-26 Gloria Melanie Chief Operating Officer -$678,603.855 Transaction at $38.31, now +1.3%
2026-06-26 Van Tuyl Christopher Chief Legal Officer -$411,962.547 Transaction at $26.76, now +45.0%
2026-06-26 Girao Tiago Chief Financial Officer -$225,600 Transaction at $27.18, now +42.7%
2026-05-29 Fromkin Andrew J. -$5.8M Transaction at $20.86, now +85.9%
2026-04-03 Venker Eric Chief Executive Officer -$3.4M Transaction at $21.22, now +82.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Immunovant Inc (IMVT) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for IMVT on Trend Edge →